The localisation and expression of 5α-reductase Types I and II mRNAs in human hyperplastic prostate and in prostate primary cultures

Journal of Endocrinology

Volumn 156, Issue 3, 1998, Pages 509-517

  Habib, F K ^a,c   Ross, M ^a   Bayne, C W ^a   Grigor, K ^a   Buck, A C ^d   Bollina, P ^b   Chapman, K ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b University Department of Surgery   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; STEROID 5ALPHA REDUCTASE;

AGING; ARTICLE; CELL CULTURE; CHROMOSOME 2; ENZYME LOCALIZATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RNA PROBE; STROMA CELL;

CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; ISOENZYMES; MALE; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC HYPERPLASIA; RNA, MESSENGER; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0031938574     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1560509     Document Type: Article

References (30)

1. Anderson KM & Liao S 1968 Selective retention of dihydrotestosterone by prostatic nuclei. Nature 219 277-279.
2. Andersson SA & Russell DW Structure and biochemical properties of cloned and expressed human and rat steroid 5 alpha reductase. Proceedings of the National Academy of Sciences of the USA 87 3640-3644.
3. Andersson SA, Bishop RU & Russell DW 1989 Expression cloning and regulation of steroid 5 alpha reductase, an enzyme essential for male sexual differentiation. Journal of Biological-Chemistry 264 16249-16255.
4. Andersson SA, Berman DM, Jenkins EP & Russell DW 1991 Deletion of steroid 5 alpha reductase II gene on male pseudohermaphroditism. Nature 354 159-161.
5. Berman DM & Russell DW 1993 Cell-type-specific expression of rat steroid 5 alpha reductase isoenzymes. Proceedings of the National Academy of Sciences of the USA 90 9359-9364.
6. Bonnet P, Reiter E, Bruyninx M, Sente B, Dombrowicz D, De Leval J, Closset J & Hannen G 1993 Benign prostatic hyperplasia in normal prostate aging: differences in Type I and Type II 5 alpha reductase steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. Journal of Clinical Endocrinology and Metabolism 77 1203-1208.
7. Bruchovsky N & Wilson JD 1968 The conversion of testosterone to 5α androstane-17 beta-ol-3-one by rat prostate in vivo and in vitro. Journal of Biological Chemistry 243 2012-2021.
8. Bruchovsky N, McLaughlan MG, Rennie PS & To MP 1981 Partial characterisation of stromal and epithelium forms of 5 alpha reductase in human prostate. Progress in Clinical Urological Research 75 161-175.
9. Chomczynski P & Sacchi N 1987 Single step method of RNA isolation by guanidium-thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
10. Enderle-Schmitt U, Volck-Badouin E, Schmitt J & Aumuller G 1986 Functional characteristics of nuclear 5 alpha reductase from rat ventral prostate. Journal of Steroid Biochemistry 25 209-217.
11. George FW, Russell DW & Wolfson JD 1991 Feed-forward control of prostate growth: dihydrotestosterone induces the expression of its own biosynthetic enzyme, steroid 5 alpha reductase. Proceedings of the National Academy of Sciences of the USA 88 844-847.
12. Habib FK 1992 Regulation of prostate growth in culture with the pollen extract, Cernitin T-60 and the impact of the drug on the EGF tissue profiles. In Benign Prostate Diseases, pp 120-128. Eds W Vahlensieck & G Rutishauser. New York: George Thieme Verlag.
13. Habib FK, Ross M, Tate R & Chisholm GD 1997 Differential effect of Finasteride on the tissue androgen concentrations in benign prostatic hyperplasia. Clinical Endocrinology 46 137-144.
14. Hirsch KS, Jones CD, Audia JE, Andersson S, McQuaid L, Stamm NB, Neubauer BL, Pennington P, Toomey RE & Russell DW 1993 LY191704: a selective, non-steroidal inhibitor of human steroid 5 alpha reductase Type I. Proceedings of the National Academy of Sciences of the USA 90 5277-5281.
15. Houston B, Chisholm GD & Habib FK 1985a Solubilization of human prostatic 5 alpha reductase. Journal of Steroid Biochemistry 22 461-467.
16. Houston B, Chisholm GD & Habib FK 1985b Evidence that human prostatic 5 alpha reductase is located exclusively in the nucleus. FEBS Letters 185 231-235.
17. Hudson RW 1981 Studies on the nuclear 5 alpha reductase of human hyperplastic prostate tissue. Journal of Steroid Biochemistry 14 579-584.
18. Hudson RW & Wherrett D 1990 Comparisons of nuclear 5 alpha reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia. Journal of Steroid Biochemistry 35 231-236.
19. Jenkins EP, Hsieh C-L, Miletovitch A, Normington K, Berman DM, Francke U & Russell DW 1991 Characterization and chromosomal mapping of a human steroid 5 alpha reductase gene and pseudogene and mapping of the mouse homologue. Genomics II 1102-1112.
20. Jenkins EP, Andersson SA, Imperato-McGinley J, Wilson JD & Russell DW 1992 Genetic and pharmacological evidence for more than one human steroid 5 alpha reductase. Journal of Clinical Investigation 89 293-300.
21. Levine AC, Wang JP, Ren M, Eliashvili E, Russell DW & Kirschenbaum A 1996 Immunohistochemical localization of steroid 5 alpha reductase 2 in the human male fetal reproductive tract and adult prostate. Journal of Clinical Endocrinology and Metabolism 81 384-389.
22. Moore E, Bracken B, Bremner W, Geller J, Imperato-Mcginley J, McConnell J, Roy J, Tenover L, Vaughan D, Pappas F, Cook T, Gormley G & Stoner E 1995 Proscar: five-year experience. European Urology 28 304-309.
23. Moore RJ & Wilson JD 1972 Localisation of the reduced nicotinamide adenine dinucleotide phosphate-delta 4-3-keto steroid 5 alpha-oxidoreductase in the nuclear membrane of the rat ventral prostate. Journal of Biological Chemistry 247 958-967.
24. Moore RJ & Wilson JD 1974 Extraction of the reduced nicotinamide adenine dinucleotide phosphate: delta 4-3-keto steroid 5 alpha-oxidoreductase of rat prostate with digitonin and potassium chloride. Biochemistry 13 450-456.
25. Rennie PS, Bruchovsky N, MacLaughlin MG, Batzold FH & Dunstan-Adams EE 1983 Kinetic analysis of 5 alpha reductase isoenzymes in benign prostatic hyperplasia. Journal of Steroid Biochemistry 19 169-173.
26. Sargent NSE & Habib FK 1991 Partial purification of human prostatic 5 alpha reductase (3-oxo-5 alpha-steroid: NADP+ 4-ene-oxido-reductase; EC1·3·1·22) in a stable and active form. Journal of Steroid Biochemistry and Molecular Biology 38 73-77.
27. Scheer H & Robaire B 1983 Solubilisation and partial characterisation of rat epididymal delta 4 steroid 5 alpha reductase (cholesterone 5 alpha reductase). Biochemistry 211 65-74.
28. Silver RI, Wiley EL, Thigpen AE, Guileyardo JM, McConnell JD & Russell DW 1994 Cell type specific expression of steroid 5 alpha reductase 2. Journal of Urology 152 438-442.
29. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD & Russell DW 1993 Tissue distribution and ontogeny of steroid 5 alpha reductase isoenzyme expression. Journal of Clinical Investigation 92 903-910.
30. Tsugaya M, Habib FK, Chisholm GD, Ross M, Tozawa K, Rayashi Y, Kohri K & Tanaka S 1996 Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia. Urological Research 24 265-271.